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This paper analyzes the sources of quality of a pharmaceutical product. After 
identifying eight quality dimensions, a framework of hypothetical sources that contribute 
the most to shape those dimensions is established.   
The framework, based on Garvin’s pioneering work, is applied to case studies of 
laboratories operating in Argentina. Framework relevance is considered using correlation 
analysis.  Laboratories are ranked through expert opinion by the quality of its products 
using the eight dimensions mentioned above; it is observed that there is no perfect 
parallelism in ranking along all dimensions, possibly revealing different managerial 
priorities and  uses of resources among laboratories, as well as different sources of quality 
and different business strategies. Correlation analysis also suggests that the study of a 
pharmaceutical product is a complex task when a modern concept of quality is considered.  
Once the existence of different quality dimensions is accepted, the following two 
questions are investigated: (1) Are there specific sources of quality that support some 
dimensions (and not others) and that are based on identifiable organizational aspects or 
specific technologies? (2) What are the generic sources of quality (affecting all dimensions) 
and in what way do they contribute to improve performance or highlight quality 
dimensions? It is assumed as a starting point that among the sources of quality there are 
generic sources, affecting all dimensions, and specific sources, which affect only some 
dimensions. In concrete cases, specific quality sources are identified, although the search 
for specific quality sources for each dimension is not conclusive. The study of generic 
quality sources, however, suggests that corporate systems, corporate culture, and 
management policies contribute to incorporate quality in a product. Thus quality results 
from the interaction between generic and specific sources.  
In the final part of the paper, recommendations for academics and industrialists are 
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Quality is not created spontaneously. It is designed and manufactured: It has its own 
sources. A somewhat elusive concept, quality is difficult to define and easy to perceive. 
This combination of traits obscures the study of factors that help to discover, produce, and 
distribute quality products and services. 
Quality presents several aspects and during the last two decades these aspects, 
called  dimensions, have started to be recognized. In his seminal work on quality 
management, which includes a study on the U.S. room air conditioning industry, Garvin
ii 
identified eight dimensions of quality, and he conceived them as a potential source of 
competitive advantages. The air conditioning study allowed him to rigorously apply quality 
dimensions, in both subjective and objective evaluations that display qualitative differences 
among different brands of air conditioners and different manufacturing plants. Garvin 
explains these differences by looking at the sources of quality and the policies and attitudes 
towards quality exhibited by managers. 
Quality is not just the result of will. It requires systems and processes to make it 
consistently viable. Quality sources and, in particular, the precise contribution of quality 
policies in a process industry, deserve study. This paper makes a qualitative exploration, 
applying the case study methodology
iii to pharmaceutical laboratories operating in 
Argentina. The paper is divided into two parts.  
In the first part, a classification of quality dimensions for a pharmaceutical product 
is introduced, and hypothetical sources that contribute the most to shape quality are 
established. This dimension classification is tentative and its main use in this work was to 
stimulate managerial judgment at the time of inquiring into the sources of quality. The 
classification is based on Garvin´s study, and it adapts his approach to the features of 
pharmaceutical products.  
In the second part, theoretical concepts from the first part are applied to the case 
study of laboratories operating in Argentina. The eight dimensions are utilized in order to 
classify, by the quality of its products, several laboratories (named 1, 2 ,3, and 4); it is 
observed that there is no perfect parallelism in rankings along all dimensions. This lack of 
parallelism reveals the existence of different managerial priorities or types of resources, and 
suggests different sources of quality as well as different business strategies among 
laboratories. In addition, it also reveals that the study of pharmaceutical product quality is 
even more complex when a modern, wide perspective of quality is adopted. Modern 
perspectives on quality go beyond its basic concept
iv, incorporating organizational arrays, 
aesthetics concepts and quality of service to the client. Through general surveys, detailed 
interviews, visits to plants and the examination of relevant documents, the way that 
management systems and other enterprise assets such as technology contribute to create 
quality in the different dimensions of a pharmaceutical product are studied. In concrete 
cases, quality sources are identified.  
In spite of the findings of the correlation study, that indicate that multiple quality 
dimensions exist, the search for specific quality sources for each dimension is not 
conclusive in this study. On the other hand, important differences among product quality 
are observed at different laboratories. These facts lead us to study generic quality sources. 
Thus, through qualitative studies, the research identifies the way in which corporate 
systems and management policies, as well as other company assets such as corporate   3 
culture, contribute to incorporate quality into the pharmaceutical product. This quality 
results, in summary, from the interaction among generic sources and specific sources. In the 
final part of the paper, reflections and recommendations are presented for both academic 
and industrial practitioners.  
 
II. FIRST PART: QUALITY DIMENSIONS AND QUALITY SOURCES 
 
II.1 PHARMACEUTICAL INDUSTRY PECULIARITIES 
 
The pharmaceutical industry follows general quality requirements common to R&D 
firms, analytical control laboratories, and chemical plants. It also has characteristics of 
regulated industries, due to its impact on people´s health. In addition, as a process industry 
that makes chemical and physical changes on materials, it has its own, specific quality 
problems, such as the following
v: 
 
à Kinetic reactions continue over time, making it necessary to protect samples 
from dispatch delay, air contamination, packaging contamination, etc.  
à Samples taken during a process can differ noticeably in composition from those 
of the finished product. 
à The product must be able to be packaged for just one application and 
nonetheless be attractive to the client. 
à Measurement methods can be diminutive processes of a chemical, physical or 
biological nature, requiring control.  
 
In addition, packaging must promote inalterability of the product and contribute to 
its preservation. 
Pharmaceutical products are manufactured in different forms: liquids, powder, 
cream, tablets, capsules, eye drops, lotion, etc. This variety, added to the wide range of 
existing medicines, each one with specific effects, complicates quality comparisons among 
products and laboratories. In this exploratory work we overcome this difficulty through the 
subjective qualification that expert judges (industrial pharmacists with long experience) 
make on diverse laboratories, establishing a ranking among them for different quality 
characteristics of their products.   
 
II.2 QUALITY DIMENSIONS FOR A PHARMACEUTICAL PRODUCT 
 
Quality is a complex concept, made up of diverse elements. In this section we break 
down the concept while applying it to pharmaceutical product, creating eight dimensions, 
classified in three different categories, as shown in Table 1.  
These dimensions tend to be thought of as mutually independent, although there are 
some mutual relationships among them; for example, there is usually a high correlation 
between performance and reliability; between perceived quality and service; and between 
conformance and aesthetics. In the following paragraphs we examine the meaning of these 
























Performance deals with the basic characteristics of a product or service
vi. For a 
medicine, its selective therapeutic action is a fundamental characteristic of performance; 
other performance characteristics are the degree of counter-productive effects the product 
presents and the adverse interactions in which the drug participates. These characteristics or 
performance components can be objectively measured
vii. 
 
II.2.2 Secondary features 
 
By secondary features we mean aspects that complement basic functions of a 
product or service. Easiness to provide the required drug amount to the patient, the degree 
of risk of alterations in the drug, and the possibility that the drug has to substitute other 
more expensive alternatives can all be considered secondary features or features. Secondary 
features are a dynamic concept that evolves with time. For instance, in diabetes treatment, 






The durability dimension relates to the period that can elapse between the moment a 
product is manufactured and the moment it is consumed. This period is in practice limited 
by the expiration date printed on the package. Since products such as food, drinks and 
medicines end their useful life a short time after consumption, the analysis of durability 
does not present technical or economic complexity, as is the case with products that 
deteriorate partially or gradually, or those that can be fixed when broken.  
 
A.  QUALITY FROM THE PRODUCT VIEWPOINT 
 
1. Performance 
2. Secondary features 
3. Durability 
 
B. QUALITY FROM THE PATIENT VIEWPOINT 
 
4. Aesthetics 
5. Perceived quality 
6. Service 
 
C.  QUALITY FROM THE PROCESS VIEWPOINT 
 
7. Conformance 




Aesthetics is by etymology a word related to perception by human senses. Thus 
taste and odor of a medicine and the visual attractiveness of a package are aesthetics 
components of a pharmaceutical product. To a large extent, these components are 
subjective, although there is usually a great deal of opinion agreement about them 
ix. 
Hygienic aspect is another component of the aesthetics dimension. 
 
II.2.5 Perceived quality 
 
Perceived quality is an indirect comparative dimension. Given the complexities of 
judging the quality of a pharmaceutical product, the public and, to some extent, the medical 
profession, base their impressions on indirect signals. Drug originality and immediate effect 




A product cannot claim great quality if it is not available at drugstores and other 
points of sale, or if interested parties cannot obtain clear, easy to read information on the 
product and its effects. Thus, product availability at pharmacies and ample distribution of 




Conformance is the degree of adherence of the design and manufacture of a product 
to accepted industrial standards. In the case of pharmaceutical  tablets, for example, 
conformance measures the presence of cracks and the correspondence between the quantity 
of tablets declared in the package and its real content. Unlike aesthetics or perceived 




Reliability is the dimension that creates in the client the mental state of security 
about the properties and effects of a medicine. The absence of adverse effects of 
components and the correspondence between dose declared in the package and its real 
contents fall under this dimension. 
 
II.3. THE SOURCES OF QUALITY 
 
Generally speaking, the sources of quality of a pharmaceutical product are found as 
much in the policies and attitudes towards quality exhibited by management and personnel 
as in the characteristics of the laboratory´s R&D processes, product design, supplier 
selection and management, operations management and human resource management. 
More specifically, the GMP (Good Manufacturing Practices) standards and the GLP (Good 
Laboratory Practices) standards are quality sources in the pharmaceutical industry. Finally, 
in an even more specific sense, it is possible to detect “specific sources” corresponding to   6 
different quality dimensions of a pharmaceutical product. Let us look at some of these 
specific sources.  
 
II.3.1 Sources of perfomance 
 
Effective therapeutical action of a drug is, in a fundamental sense, a function of  the 
R&D laboratory activity. The laboratory invents the product, defines production 
technology, identifies adverse reactions that could cause quality problems or performance 
reduction, collects data to design the manufacturing plant, and establishes control 
parameters based on theoretical considerations on where, when, and how to perform the 
control process. Likewise, minimal contraindications are searched through the R&D work. 
 
II.3.2 Sources of secondary features 
 
Just like performance, secondary features derive from the R&D laboratory, but in 
more advanced stages of the R&D work; at these stages, pharmaceutical presentations that 
are more convenient for the patient are sought. For example, thanks to R&D an injectable 
medicine could become a nasal aerosol. 
 
II.3.3 Sources of durability 
 
Medicine durability is associated with aspects such as packaging (which protect the 
product against contamination and excessive heat, light or humidity) and pharmaceutical 
formulae. Durability of a medicine is born at the development stage of the pharmaceutical 
form, when drug characteristics as a function of time and its effect on the human organism 
are studied. In addition, durability depends on the degree of observance of manufacturing 
conditions, the type of equipment used in each manufacturing country, logistics, and other 
factors. 
 
II.3.4 Sources of aesthetics quality 
 
To some extent, quality in its aesthetics dimension is obtained by rigorously 
applying the GMP standards, by providing good training and work habit formation, by  
achieving hygiene in all processes, by having permanent control of supplies and even by 
insuring good personal appearance in the laboratory sales force.  
 
II.3.5 Sources of perceived quality 
 
As we mentioned above, indirect signals such as the quality of publicity, which over 
time creates brand image is a source of perceived quality. The country of origin effect also 
contributes to the perception of a product quality
x. Drug originality, especially when it is 
promoted through the mass media, and immediate effect (without adverse symptoms) of a 
medicine are further aspects of perceived quality. Likewise, the laboratory history and the 
quality of information delivered to doctors, pharmacists, and other stages of the health care 
chain integrate the perceived quality dimension. 
   7 
For these reasons, institutional marketing is a major source of the perceived quality 
dimension.  Communication components in marketing play a central role in shaping the 
laboratory image and its brand image. However, in the long run a good marketing approach 
is not enough if the company products are not valuable. For this reason, drug suppliers are a 
key source of quality; in particular, the origin certificates of the supplies enhance perceived 
quality among the pharmaceutical profession. 
 
II.3.6 Sources of service quality 
 
To a great extent, service quality is a consequence of customer-oriented logistics. A 
good sales forecasting system, for example, can contribute to improve availability at 
pharmacies of the laboratory products, thus enhancing service quality. In principle, the 
marketing strategy of the firm, and the larger or shorter time horizon it defines in its 
relationship with clients will shape service logistics. 
 
II.3.7 Sources of conformance 
 
The manufacturing process, in particular, respect for manufacturing standards, is at 
the roots of conformance. Manufacturing for conformance requires respect for tolerance of 
mix proportions and observance of master specifications of components and final products. 
 
II.3.8 Sources of reliability 
 
GMP and GLP standards, if correctly applied, are the basis of reliability; when 
GMP and GLP are implemented, robust quality assurance systems operate to increase 
reliability. These systems must be well designed, implemented and controlled, and adequate 
personnel and equipment are required in order to get quality objectives.  
Table 2 summarizes typical components for each one of eight dimensions and  
specific quality sources. 
 
 
Table 2.  Examples of quality dimension components and specific quality sources for a 
pharmaceutical product. 
Performance Secondary Durability Aesthetics Perceived Service Conformance Reliability
features quality
Therapeutic action Convenient form Adequate packaging Hygienic aspect Drug originality Availability at No cracks Only declared drugs 
Minimal adverse effects Lack of adulteration Quick effect with no pharmacies Only the indicated  and quantities.
Minimal interaction Can replace more  adverse effects Clear and legible  number of pills is  Legible batch.
expensive product History of laboratory information present.
Easiness to complete (This dimension differs
treatment according to 
Selectivity presentation form.
R&D Formulae development Development and  Existence of process Drug origin certificate CRM Master specification GMP and GLP 
Synthesis of new Clinical tests standardization of  control program Institutional  Customer oriented,  of components and application
chemical formula Pharmaeconomic materials Existence of batch marketing long term marketing finished products Existence of robust
Pre-clinic tests studies liberation system strategy Observance of  QA system.
manufacturing norms.
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III. PART II: CASE STUDIES 
 
III.1 FRAMEWORK AND RESEARCH QUESTIONS 
 
Positive attitudes towards quality and the implementation of appropriate 
management systems greatly promote improvements in the quality of a product or service. 
Quality sources of a pharmaceutical product can be classified into generic sources and 
specific sources. The former include categories applicable to all kinds of products, such as 
the quality of supplies provided by third parties, or the attitudes toward quality exhibited by 
managers; among generic sources we point out corporate culture, due to its importance. On 
the other hand, specific sources are those that hypothetically explain specific quality 
dimensions. The causal relationship between quality and its sources is graphically presented 











Figure 1. Framework of reference. Quality dimensions obey to both specific and generic 
sources. 
 
The reference framework invites to ask two questions, which will orient the case 
studies:  
 
1. Are there specific sources of quality that support some dimensions (and not others) 
and that are based on identifiable organizational aspects or specific technologies? 
2. What are the generic sources of quality and in what way do they contribute to 
improve quality performance or highlight quality dimensions? 
 
III.2 SPECIFIC SOURCES OF QUALITY 
 
Does it make sense to talk about specific sources of quality for a pharmaceutical 
product?  Lets us examine these sources, that is, those that give origin to the eight 
dimensions presented in the first part of this paper and ask, in the first place, if these 
dimensions have enough entity to allow discrimination among independent aspects that are 
useful from the viewpoint of quality management. We start from the idea that these 
different quality dimensions exist with their own entity, otherwise it would be meaningless 
to search for specific, independent sources for each dimension.  
In order to check in an exploratory manner the discriminative power of quality 
dimensions of a pharmaceutical product, we did a small survey among four professionals 
(three pharmacists and one industrial engineer) with industrial experience
xi. The object of 
this survey was to check to what extent quality dimensions differ among themselves. 
· Specific sources of 
quality 
 






· Quality dimensions   9 
Interviewed people were asked to establish, for the set of eight dimensions, a ranking of 
four laboratories identified by their names in the survey and numbered from 1 to 4 in this 
study for confidentiality. In the first column of Table 3 the eight dimensions are shown. In 
the second column effective sample size for each dimension is listed. The remaining 
columns present average expert rankings for all dimensions. Thus, for example, in the 
Performance dimension, Laboratory 1 was classified in the fourth place by the four experts 
(average ranking = 4) while in the Service dimension it obtained much better qualifications 
(average = 1.25). Laboratory 1 is relatively well considered (low ranking) in a few 
dimensions, while its reputation in other dimensions is not so favorable. This suggests that 
different dimensions effectively measure different concepts, as we had hypothetically 
established. Other laboratories present a smaller dispersion among dimensions, which could 
mean either that the laboratory “is good at everything” or else that, although in different 
ways, we are measuring variables which are conceptually close to each other
xii. The last 
row in Table 3 indicates the average ranking in all dimensions for all four laboratories.  
 
  Sample 
size 
Lab 1  Lab 2  Lab 3  Lab 4 
Performance  4  4  1  2,25  2,75 
Secondary features  2  3  2  3  2 
Durability  4  4  1  2,25  2,75 
Aesthetics  4  2,67  1  3,5  2 
Perceived quality  4  3,25  1  3,5  2,25 
Service  4  1,25  1,75  3,25  3,75 
Conformity  4  4  1,75  2  2,25 
Reliability  2  4  1,5  3  1,5 
AVERAGE    3,27  1,37  2,84  2,41 
 
Table 3. Position rankings for four laboratories in each one of eight quality dimensions of a 
pharmaceutical product. Values are estimates of industry experts. The meaning of extremes 
values is: 4 = Worst, 1 = Best; intermediate values are 3 and 2.  
 
A standard way to examine the degree to which different dimensions are linked 
among themselves is to analyze its correlation matrix. This matrix (Table 4) shows the 
correlation coefficients among each quality dimension and all the others. For example, 
given that the correlation coefficient between durability and conformance (0.90) is close to 
1, it is estimated that both dimensions move together and it would not be unreasonable to 
assume that they obey to a common mechanism. Likewise, the aesthetics and perceived 
quality dimensions are highly correlated. On the contrary, aesthetics with service, as well as 
aesthetics with conformance, are not highly correlated. It must be borne in mind that this is 
an exploratory analysis, in which variables and their relationships are studied just to orient 
the analysis
xiii (inferences are not to be drawn). In this case, analysis leads us to ask if there 
are any mechanisms, called sources, that systematically produce quality and that could 
correctly be associated with specific dimensions.    10 
 
  Secondary 
features 
Durability Aesthetics  Perceived 
quality 
Service Conformance Reliability 
Performance  0,58  1,00  0,54  0,72  -0,14  0,90  0,74 
Secondary 
ffeatures 
  0,58  0,86  0,89  -0,24  0,57  0,94 
Durability      0,54  0,72  -0,14  0,90  0,74 
Aesthetics        0,97  0,28  0,31  0,71 
Perceived 
quality 
        0,15  0,52  0,81 
Service            -0,55  -0,46 
Conformity              0,80 
 
Table 4. Correlation matrix of rankings for four laboratories. All possible pairs are 
considered. Data are taken from Table 3. 
  
In Table 5 correlation information among dimensions is presented, grouped into 
four categories: Very strong, Strong, Weak, and Very Weak or Negative correlation. These 
categories were obtained by ordering correlation coefficients in Table 4 and dividing the 
resulting list in quartiles. The table is self-explanatory. 
 






Very weak or negative 
correlation with 
Performance   Durability 
 Conformance 
 Perceived                             
quality 
 Reliability 
 Secondary features 
 Aesthetics 
Service 
Secondary features  Aesthetics 
Perceived quality 
Reliability 








 Secondary features 
 Aesthetics 
Service 
Aesthetics  Secondary features 
Perceived quality 









 Conformance  Service 











 Secondary features 
 Aesthetics 
Service 





  Service 
 
Table 5. Correlation among dimensions: qualitative view.    11 
 
As a result of this initial examination of correlation information,  it can be sustained 
that there could be multiple, independents sources of quality, corresponding to an 
equivalent number of relatively autonomous dimensions. These specific sources will be 
analyzed in the case studies. 
 
III.3 GENERIC SOURCES OF QUALITY 
 
Generic sources of quality are relatively well understood. Garvin (1988) presents 
the following generic sources, which are also applicable to the pharmaceutical industry in 
general:  Company policies and attitudes towards quality, characteristics of its R&D 
activities, product design process, supplier selection and management, manufacturing 
management and personnel management. To these generic sources, the GMP and GLP 
standards, as well as technology, should be added. Corporate culture must also be 
considered, since it is a system that surrounds management decisions and determine, to a 
greater or lesser extent, how employees act. Let us consider some of these sources as they 




Technology used in the pharmaceutical industry deserves special attention. Given 
that, in some sense, quality is the absence of variability in processes and results, plants that 
incorporate a higher degree of technology
xiv will tend, in general, to produce better quality: 
machines and physical systems are less exposed to variation than human beings, whose 
work depends upon a great number of difficult to control factors. 
Incorporating technology into processes allows greater consistency and less 
variability in critical attributes of the pharmaceutical product. With higher mechanization, 
operations that affect quality can be made more efficient: for example, distribution lag 
times can be shortened, improving service; likewise, the number of rework processes 
performed for lack of conformance with specifications is diminished.  
Technology allows reduction in the manual handling of some operations that affect 
hygienic conditions and, occasionally, the aesthetics of the final product. In addition, in 
recent years new materials technology has favorably impacted durability, allowing for 
wider and more complete distribution operations. 
 
III.3.2 Supplier selection and management 
 
In general, supplier selection and the relationships established with suppliers is 
better managed when a manufacturer deals with expensive inputs or with supplies that have 
a great potential impact on the quality of a final product. In recent years, the concept of 
certified quality has been widely developed and applied in the pharmaceutical industry. 
 
III.3.3 Human resources  
 
Human resources must be at the core of any quality policy for leading 
manufacturers. Human resource policy is the basis on which application of GMP standards 
is conducted and it must be lead by top management. Plant personnel attitudes and practices   12 
must be aligned with the values transmitted from the top. 
 
III.3.4 Corporate culture 
 
Corporate culture is “the way companies do things”. Quality culture, for i nstance, is 
the way organizations develop their efforts to get systems, processes, and products and 
services of high quality. Culture is a system of symbols, values, myths, and practices that 
slowly evolve through time. Corporate culture has several elements; some authors
xv 
consider the following:  
 
¨ Member identity (degree to which the personnel identifies with the organization 
as a whole, rather than with the kind or work that each person does) 
¨ Group emphasis to perform tasks (degree to which activities organize around 
groups rather than individuals) 
¨ People focus (degree to which preoccupation of management related to the 
impact that their decisions have on personnel) 
¨ Unit integration (degree to which coordinated work among units is promoted) 
¨ Conflict tolerance (degree to which personnel is encouraged to openly face 
conflicts and criticism) 
¨ Control (degree to which rules and direct supervision are used to control 
employees´ behavior) 
¨ Risk tolerance (degree to which employees are encouraged to be innovative and 
risk takers) 
¨ Reward criteria (degree to which rewards are given on the basis of performance 
or other factors) 
¨ Means and ends orientation (degree to which importance is given to results over 
processes used to get them) 
¨ Open systems approach (degree to which the organization observes the external 
environment and responds to it) 
 
An organization is made of people working in teams to produce results, by means of 
processes that have their own control mechanisms. Among the inputs required by any 
organization to perform its activities is information; information is captured and used more 
or less profitably according to the open (or closed) systems approach taken by the 
organization. Using these four classes: group functioning, control style, concern for means 
and ends and attitude towards open systems, it is possible to group the 10 elements of 
culture presented above in a more manageable set, as shown in Table 6. 
 
   13 
Class  Elements 





Control style  Control 
Risk tolerance 
Reward criteria 
Concern for means and 
ends 
Means and ends orientation 
Attitude towards open 
systems 
Open systems approach 
 
Table 6.  Culture elements are arranged in classes to conform a smaller, more manageable 
set. 
 
III.4. CASE STUDY 
 
Through a two laboratory case study we try to answer the research questions posed 
earlier in the paper, that is, whether there is evidence linking strong specific quality sources 
with better quality results, and eventually determine mechanisms that act so that these 




III.4.1 General characteristics of the laboratories 
 
Laboratory 1 is an Argentine firm, while Laboratory 4 is the Argentine subsidiary of 
a multinational company. Both companies have a long history in Argentina
xvii. In the 
average ranking of laboratories according to product quality (Table 3) they had occupied 
positions 4 and 2, respectively.  
Table 7 summarizes general characteristics of the laboratories and their markets, 
leadership styles and internal processes. Both firms operate in competitive markets, 
although Laboratory 1 deals with an homogeneous market through disperse marketing and 
production activities, while Laboratory 4 faces an heterogeneous market by realizing 
relatively fewer, more concentrated activities. 
In general, Laboratory 1 is, in leadership terms, a follower, not too much inclined to 
innovation or change, with relatively unrefined management systems. Although it produces 
quality products, performance as measured by sales volumes, market share, profitability, 
and other indicators tends to be unsatisfactory. 
On the other hand, Laboratory 4 can be described as a leader firm, oriented to 
innovation, that actively seeks change and has advanced management systems to project 
itself into the future. The result of these forces is a relatively satisfactory performance, with 
products of satisfactory quality.    14 
 








Very disperse  Concentrated 
Leadership  Follower  Leader 




Job descriptions, standard costing 
systems, short term planning systems. 
Job description, standard costing systems, 
performance evaluation systems, monthly 
operating report, MBO, manager´s training 
programs, objective formula for salary 
determination, fixed assets investment 
system, sales forecasting system, sales 
review and analysis system, sales force 
performance evaluation system, 
competitor´s analysis, price and publicity 
planning, cash flow planning system, short 
and medium range planning system, 
strategic planning system, capital budgeting 
system, financial investment system, 
program and budget system, SBU system, 
project management systems, product and 
brand management systems, organization 
matrix system, MIS. 
Job 
descriptions 










Tends to insatisfactory  Tends to satisfactory 
Product 
quality 
Tends to satisfactory  Tends to satisfactory. 
 
Table 7.  Comparison of Laboratories 1 and 4 regarding markets, processes, quality, and 
leadership styles. 
 
The results of both laboratories in terms of quality and other operating indicators are 
not easy to compare. However, we have relatively strong evidence of the superiority of 
Laboratory 4. In fact, besides the judgement of four experts, managers at both laboratories 
gave us their opinions on the quality of their products and a variety of other indicators 
(please see the Appendix). 
 
III.4.2 Specific sources of quality: comparative study 
 
Specific sources of quality highlighted by experts at each laboratory are shown in 
Table 8. The comparison is not clear-cut. Although in Table 3 we saw that Laboratory 4´s 
product quality is better regarded than that of Laboratory 1 in seven out of eight dimensions   15 
(service quality being the exception), from the information we have, there is no clear 
evidence of the superiority of Laboratory 4´s mechanisms over those of Laboratory 1 to  
produce quality. There do exist, however, differences between the nature of the 
mechanisms that laboratories use to produce quality. Let´s analyze similarities and 




Laboratory 1  Laboratory 4 
Performance  Drug and market evolution at the 
advanced countries is followed 
through the activities of an ad-hoc 
committee. 
Pre-clinic tests are performed. For example, 
bio’equivalence tests, double blind tests. 
GMP: Personnel training at the classroom 
and the plant. Critical points studies. 
There exists a quality assurance system. 
Secondary 
features 
There is a Development Department 
that develops the pharmaceutical 
form of the product. 
 
There is no Development Laboratory. The 
formula is selected among a range of 
alternative formulas according to drug 
availability in the local market or at the 
supplier that the laboratory usually deals 
with.  A small lot is prepared for analysis and 
stability and once approved it is made on an 
industrial scale. 
Durability  The Development Department  
conducts studies of natural and 
accelerated stability. What is required 
by the Health Authorities is done. 
Stability studies are performed under local 
conditions (for the local market) and with 
special conditions (for the regional market). 
 
Aesthetics  Aesthetics is very important, 
specially when dealing with medical 
samples. Sometimes external 
agencies are contracted for package 
design. Specifications and standards 
of packaging machinery are 
respected. Process control with 
check sheets is carried out. There are 
650 procedures for plant quality. 




There is a customer care service. 
Each claim is followed and acted 
upon (reactive control). 
Supplies are bought from the head company 
or from suppliers with international 
reputation and acceptance. As a byproduct 
this fact creates a quality image. 
Service  The laboratory has its own 
distribution network, including an 
urgency service. There are company 
distribution centers in the interior 
cities. 
Distribution is contracted. There is an 
information system that performs sales 
follow-up. 
There are standards for printed materials. 
Conform-
ance 
There exists a productivity record 
sheet for one of the product lines. 
GMP standards are applied. 
Processes are adjusted to master registers so 
that consistency is guaranteed. 
Reliability  Reliability standards for 
multinational companies are 
followed. The laboratory is about to 
completely apply the OMS ´92 GMP 
standard. 
The reliability of factory operations is 
constantly kept in line with GMP demands. 
There are auto-inspections and international 
audits to check the normal work of all plant 
processes. 
 
Table 8. Specific sources of quality corresponding to different dimensions for both 
laboratories.   16 
 
Both laboratories seem to have their own pattern of responses to the challenge of 
obtaining quality in its different dimensions. Laboratory 1 exhibits the use of units such as 
departments or committees, or systems, as well as adherence to standards; regarding 
service, they have their own distribution system. Laboratory 4, on the other hand, highlights 
tests and research studies, as well as training and relationships with international firms, 
standards and audits. The role of the GMP standards is important for both laboratories and 
the experts mention them as a source of quality for several dimensions, such as reliability 
and conformance. 
 There is a general perception of a proactive attitude and great deal of strictness at 
Laboratory 4. For each dimension, sources are identified that imply concern for operations, 
the observation of international standards or an active interaction with suppliers. For 
example, in order to enhance the performance dimension, pre-clinical tests are performed, 
personnel is trained in GMP standards, plant critical points are studied and a quality 
assurance (QA) program is applied. In the aesthetics dimension, international standards are 
applied to packaging. To get reliability, production operations are constantly kept in line 
with GMP guidelines, auto-inspections are performed and international audits examine 
factory processes. 
 Laboratory 1 presents a set of specific sources somewhat more “passive.”  This 
phenomenon is particularly noticeably in the performance dimension: There is an ad-hoc 
committee that follows the evolution of the most important drugs and markets; although the 
functions of this committee are adequate for the laboratory needs, it is not less true that, for 
not paying attention to other sources, opportunities to develop good management practices 
are lost. It is important to discriminate quality sources for each dimension as they allow to 
clarify specific aspects of management. For example, by noticing the good reputation that 
the service of Laboratory 1 enjoys in the market, it is possible to inquire into the sources of 
this reputation and determine that customer service and its own distribution system, 
including an urgency system, are the primary sources of quality in this dimension. 
Eventually this information could be used for new corporate developments, especially in 
light of a new competitive environment that will be stimulated by the new patent law in 
Argentina. 
 
III.4.3. Generic Quality Sources: Application to Laboratories 1 and 4 
 
III.4.3.1 Technology  
 
Since product lines differ, comparison of Laboratories 1 and 4 along the technology 
variable is not direct. In general terms, however, some contrast is detected between 
technologies used by each laboratory. Laboratory 1 utilizes intermediate technology and, in 
general, it presents relatively low mechanization indexes: An index of 0.14 corresponds to 
an average manufacturing line. On the contrary, Laboratory 4 employs in its operations 
relatively advanced technology, with high mechanization indexes going from 0.85 in the 
packaging areas to 1 in manufacturing. 
 In the search for quality products, at both laboratories there is a tendency towards 
plant specialization by technology or by products; specialization brings scale advantages 
and process improvements for greater profitability and quality. Although technology 
applied to processes is common to both firms, there are differences in favor of Laboratory 4   17 
in the quality of the attention paid to each manufacturing stage. These differences are 
reflected, for example, in the quality, relevance, and quantity of documentation produced 
and kept up to date, including operations records.  
 
III.4.3.2 Human Resources Management 
 
At both laboratories top management personally oversees human resources issues. 
There are, however, differences in the approach to hiring decisions; while Laboratory 1 has 
shorter planning horizons, Laboratory 4 is capable of designing a long-term personnel 
strategy.  
 Laboratory 4 is “quite modern” an enterprise, which allows even its lower rank 
employees to be informed about corporate policies. Nonetheless, just as in the case of 
Laboratory 1, it gives a rather scant importance to middle management suggestions. 
Laboratory 4 provides a more intense TQM training than Laboratory 1, and this has an 
impact on human resource management. 
 
III.4.3.3 Compared Cultures 
 
Corporate culture strongly conditions, although not always in a conscious way, 
personnel actions. When studying generic sources of quality, culture comparison is 
important as it orients the selection of means and ends for quality creation. In Table 9, our 
observations on culture at both laboratories are shown, classified according to the 
framework of 4 classes and 10 aspects. 
 Laboratory 1 is a family enterprise with which its personnel develops strong ties, 
but the firm cannot integrate units and people in teamwork due to a strong tendency to 
individual work. There is a lack of systems, for example, to solve conflicts and a lack of 
“process culture” to get objectives; results are valued higher than the means used to get 
them. Top management attitude towards risk not only conditions employee  behavior but 
also the ability to innovate and learn from interacting with the environment or just watching 
it. 
 Laboratory 4, on the other hand, operates in a network of international subsidiaries. 
Its culture, although in a state of flux due to a recent merger, gives priority to long term 
values, such as professional development of its personnel and the creation of quality 
products in a teamwork environment. Risk taking is encouraged to some extent (when no 
great economic risk exists). In general, corporate culture promotes order and the utilization 
of standard processes. 
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Class  Aspect  Laboratory 1  Laboratory 4 
Group  Member 
identity 
Personnel feels identified with the 
company (this is a majority opinion, 
but not unanimous). 
The laboratory is the result of a recent 
merger: there is a culture change going 
on. Values are being operationalized. 
There is no fix identity yet. However, 
quality is a priority, while before the 
merger costs were the key. The long 
term is considered, although stock 
prices are also important. Innovation 
and quality are paid attention.  “Deming 
is present at the company.”  
  Group 
emphasis 
Teamwork is promoted at the plant 
level, but there is a tendency towards 
individual work. 
 
There is a tendency to teamwork. 
Communication is somewhat informal, 
inside the limits allowed by standards 
and regulations. Information is widely 
shared. 
  People focus  Family enterprise, with a family-like 
environment. 
The organization highly values 
individual development in a 
professional community. 
  Unit 
integration 
There are “small societies” that form 
around specific needs. However, there 
is not a strong relationship  between 
administration and other functions. At 
the plant level integration is felt, but, 
although there is a consensus about the 
advantages of teamwork, this is not 
always achieved due to a tendency 
towards individual work. 
There are some actions that reflect the 
initial stages of a more integrated kind 
of work. These actions are centered 
around a control panel. 
 
  Conflict 
tolerance 
There are no established techniques for 
conflict resolution. Some people have 
their own strategy to deal with conflict 
and are successful. Others do not. 
Communication workshops are 
organized. Inter-departamental relations 
are enhanced taken as focus the concept 
of internal client. 
Control  Control  Work is quite liberal.   Work is organized around annual 
objectives with annual feedback and 
rewards. 
  Risk tolerance  Risk taking is encouraged as long as 
no economic risk is at stake. 
 
There is not much room for taking 
economic risks, but (only) as a principle 
risk taking is encouraged. 
  Reward 
criteria 
There is no system.  There is a bonus system for key 







Results have priority.  Processes are evaluated through 
performance indicators that divide 







Sometimes there is an open attitude 
towards the external world, but what is 
seen outside is not applied at the 
laboratory. “I like it, but I don´t like to 
invest and spend money.” Extreme 
conservatism and austerity are 
obstacles to openness and change.  
A new and truly systemic culture is 
being sought. This culture will integrate 
all employees, who are increasingly 
conscious of the company values and 
vision. A systemic attitude provides 
more realism to the change process. 
 
 
Table 9. Comparison of laboratories along 10 aspects of organizational culture. 
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III.4.3.4 Attitudes toward quality and quality systems 
 
It is reasonable to think that the attitudes towards quality of personnel and 
management, as well as the quality systems implemented at a company will condition 
quality results and explain (at least in part) differences among laboratories. In this section 
we explore the relationship between attitudes and quality, and between systems and quality 
through survey results. 
Table 10 summarizes results of a questionnaire survey answered by quality experts 
at both laboratories
xviii. The answers were grouped to form families of similar ideas 
(affinity). Each frame encloses one family of ideas. The leftmost column shows each family 
name. The second column provides the content of the question, using affirmative sentences. 
Columns third and fourth present the points given to each answer by the interviewed 
professionals at Laboratories 1 and 4, respectively, using a scale from 1 to 5 where 1 means 
“total agreement” and “5” “total disagreement”.   
At the bottom line of each frame the response average for each laboratory has been 
calculated: Given that statements are in line with good quality management practices, a 
lower average implies greater proximity to quality. In this sense, Laboratory 4 is stronger 
than Laboratory 1 regarding its general view of quality, plans and objectives, procedures 
and systems, application of modern concepts, information handling and human resources 
management. However, in terms of quality costing, Laboratory 1 is in a better position than 
Laboratory 4. In the last family of ideas, process and results, numerical values are not 
necessarily related to either good or bad practices, but the current mainstream of quality 
thought suggests the convenience of focusing on processes
xix (rather than results, since 
these will emerge from good processes). In this sense Laboratory 1 would be better 
positioned than Laboratory 4. In general, conclusions than emerge by looking at different 
families are internally consistent, as are the answers inside each family of ideas. Column 
“Diff.” in Table 10 shows, for each family, the difference between average qualification for 
each laboratory. The greatest difference occurs at “general view of quality”, which is the 
foremost component in a change process. 
 
Family  Concept  Lab.1  Lab. 4   Diff. 
 In all areas there are procedures to obtain quality.  4,00  2,00   
 There are guidelines on quality for all activities.  4,00  4,00   
   Quality policy is applied in the whole organization.  4,00  2,00   
General view 
of quality 
Quality affects every area of the organization, not just 
Production.  
2,00  1,00   
  Management pays attention to quality as much as to other issues 
and activities. 
4,00  2,00   
  There are guidelines to promote the participation of everyone in 
quality related activities. 
4,00  4,00   
 The organization is conscious about the importance of quality.  4,00  3,00   
 AVERAGE  3,71  2,57  1,14 
 
Table 10.  Comparison between laboratories on mechanisms for and attitudes 
towards quality. (Continued.)   20 
 
 The level of quality in products and services is evaluated.  2,00  4,00   
Plans   Improvement proposals with action plans are produced.   3,00  2,00   
and  Problem analysis produce quality improvements.  2,00  2,00   
objectives  Quality plans are developed to achieve objectives.  4,00  2,00   
 There are objectives for each quality indicator.  4,00  4,00   
 Quality objectives are evaluated.  4,00  2,00   
 AVERAGE   3,17  2,67  0,50 
         
 The quality system is described in writing.  4,00  2,00   
 The quality system includes auditing procedures applicable in 
each area. 
3,00  2,00   
Procedures   There are procedures for quality analysis of internal operations.  2,00  4,00   
and  Analysis methods allow setting priorities for improvement.  3,00  2,00   
systems  Quality consciousness and motivation campaigns are performed.  4,00  4,00   
 There are procedures to present results and get recognition.   4,00  4,00   
 AVERAGE   3,33  3,00  0,33 
         
 The criteria “Do it well the first time” is widely shared.   2,00  2,00   
Application of  Quality is an investment, not a source of expenses.  3,00  2,00   
modern  The concept of internal client is applied.  4,00  2,00   
concepts  Satisfying both internal and external clients is a  company 
policy. 
4,00  4,00   
 Prevention and early defect elimination are used.  4,00  4,00   
 AVERAGE   3,40  2,80  0,60 
         
 Market analysis on product quality  4,00  4,00   
 Company results are widely and adequately informed.  4,00  3,00   
Information  Quality is actively explained to customers.  2,00  2,00   
handling  There exists a quality information system.  4,00  4,00   
  The quality information system has information on activities, 
indicators, cost, etc. 
4,00  4,00   
 The quality information system has information on clients, 
competitors and suppliers. 
4,00  4,00   
 Information from the quality information system is used as a 
management tool. 
4,00  2,00   
 AVERAGE   3,71  3,29  0,43 
         
 There are procedures for estimating quality costs.   4,00  5,00   
 The cost of no quality is accounted for.  4,00  5,00   
Quality   Quality costs discriminate by prevention costs, etc.  5,00  5,00   
costing  Quality costs are calculated in all areas.  4,00  5,00   
  There is a system to manage quality costs and their evolution.   4,00  5,00   
 The company regularly establishes objectives for quality costs.   4,00  5,00   
 AVERAGE  4,17  5,00  -0,83 
         
Process  Quality efforts focus on activities and processes.  2,00  4,00   
or results  Quality efforts focus on products and services.   3,00  2,00   
         
Table 10.  Comparison between laboratories on mechanisms for and attitudes 
towards quality.   21 
 
III.4.3.5 Corporate culture, attitudes, and systems 
 
As can be seen in Table 11, corporate culture has an impact on different aspects of 
quality management, including attitude formation and smaller or greater easiness to  
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Table 11. Ways in which corporate culture contributes quality systems and attitudes.   22 
 The table shows a theoretical framework that relates central concepts of corporate 
culture with the core attitudes and systems of quality management explained in Table 10. 
 
III.4.3.6 Case study results 
 
The case study leaves several teachings
xx. Here we summarize the most important 
ones. 
 
· Quality dimensions of a pharmaceutical product. Are there mutually independent 
quality dimensions for a pharmaceutical product? The case evidence suggests that there 
are.  Although correlation among some pairs of dimensions is high
xxi, other correlation 
measures are low, indicating independence among the concepts measured by each 
dimension. It is not possible to say that the number of dimensions is exactly eight, but 
it is possible to conclude that there is a plurality of them. At any rate, independently of 
the statistical analysis, in the course of the case we assumed that the eight dimensions 
have a conceptual substratum and on this basis we used them. Confirmatory statistical 
analysis demands an important amount of data, far greater than the amount we have at 
this time.  
 
· Specific sources of quality.  The assumption that quality dimensions have their own 
entity invites to study the existence of specific sources of quality for each dimension. 
This is one of the research questions posed above. Table 12 shows identifiable 
organizational aspects and specific technologies that act as a source of quality for each 
dimension.  
 
Dimension  Quality sources for each dimension 
Performance  ¨ Statistical Analysis 
¨ Training 
¨ Quality Assurance Systems 
¨ Access to up-to-date information 
Secondary features  ¨ Development at the laboratory 
¨ Deals with trustworthy suppliers 
¨ Small scale tests 
Durability  ¨ Stability studies 
¨ Official rule observance 
Aesthetics  ¨ Specialized suppliers 
¨ Standards observance 
¨ International standards 
Perceived quality  ¨ Customer support system 
¨ Deals with world class suppliers 
¨ Marketing efforts oriented to create 
brand image 
Service  ¨ Ownership of distribution service 
Conformance  ¨ Standards observance, including GMP 
Reliability  ¨ GMP and other international standards 
¨ International audits 
 
Table 12.  Mechanisms that produce quality in its diverse dimensions. 
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This table, based mainly on Table 8, is a stock of methods that both laboratories use 
(albeit somewhat unconsciously) to work on each quality dimension; however, it does 
not allow to establish the superiority of some mechanisms over others to achieve 
quality. A more in-depth causality study would be required, as it could help to focus 
strategic choices, means and ends. 
 
· Generic sources of quality. Our second research question inquired into generic sources 
of quality, which contribute either to improve quality performance as a whole or some 
quality dimensions. These sources appeared as indeed important, especially as builders 
of institutional support on which specific sources operate. For example, it would be 
worthless to conduct pre-clinic studies (specific dimension of performance) if there is 
no set of GLP standards (generic source) that assures quality. Generic sources include 




IV.1 RECOMMENDATIONS FOR MANAGERS 
 
· Understand the dimensions of quality. Managers should consider a more detailed 
analysis of quality dimensions in order to have better strategic alternatives. Good 
knowledge of quality sources would allow for greater leverage. For example, the use of 
available resources for customer care could expand the range of business opportunities 
for the laboratory.  
 
· Need to discriminate among concepts. It is important to understand the competitive 
potential of laboratories, especially that of the smaller ones. It could be said that, 
because it is international, Laboratory 4 “has everything”: financial resources, advanced 
technology, brand and country of origin image, culture of quality, R&D, etc. These 
advantages are indeed real, but, as we saw regarding customer service, it is possible to 
find quality dimensions in which laboratories (like Laboratory 1) with fewer resources 
have strategic advantages. Discrimination among dimensions helps to improve 
understanding, increases industry know-how, and allows its application to other fields 
with potential interest. Our fieldwork suggests that in this industry there is no clear 
understanding of what the quality sources for each dimension are. There might not even 
be a clear a understanding of generic sources beyond GMP and GLP. However, if 
quality dimensions and quality sources are not understood, innovative competitive 
strategies that take advantage of them cannot be designed. 
 
· Attention to generic sources of quality. Specific sources do not explain by themselves 
all quality differences: in fact, generic sources also contribute to quality. For example, 
Laboratory 4´s technology has a high mechanization index and this is a quality source 
benefiting several dimensions. Likewise, human resource management (including 
training) is broader and deeper than that of other laboratories and contributes to increase 
the quality gap. 
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IV.2 RECOMMENDATIONS FOR ACADEMICS 
 
· Need for a more complete statistical study. For operative reasons this study database 
is small. In further studies it would be advisable to enlarge the database and compare 
analysis results. 
 
· Study of the causal mechanisms that produce quality for each dimension. It would 
be important to study more in-depth those mechanisms that shape quality in each of its 
dimensions. This understanding would help to apply the right tools and methods with 
more consistency and simplicity.  
 
IV.3 ADVICE FOR BOTH MANAGERS AND ACADEMICS 
 
· Define alternative strategies on the basis of quality dimensions. Greater 
understanding of quality dimensions in a pharmaceutical product should serve a 
laboratory as a basis to design alternative strategies allowing to better compete with 
other laboratories on the basis of its own advantages, placing itself on specific quality 




The paper integrates a number of concepts related to quality and quality 
management, with emphasis on the pharmaceutical industry. In particular, the treatment, 
through a case study, of corporate culture and corporate systems at two laboratories in 
Argentina, as well as and their impact on quality management, is reasonably developed. 
The work provides useful advice on quality-related subjects to practitioners in different 
fields. 
Further research could confirm the validity of our study by means of a wider survey. 
In addition, a more detailed analysis of cause-effect mechanisms operating to produce 
quality would be beneficial. 
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APPENDIX 
 
RELATIVE PERFORMANCE OF LABORATORIES 
 
Performance evaluation is not an easy task. Although simple forms of evaluations (such as 
revenue annual growth rate or internal rate of return) can be adopted, performance of a 
complex organism such as a business firm deserves consideration of multiple factors. Due 
to information limitations, we have based our comparison between Laboratories 1 and 4 on 
our informants’ criteria. In a 1 to 5 scale, where 1 is “great displeasure” and 5, “very 
satisfactory”, managers at the laboratories evaluated indicators as shown in Table A1. 
 
Area  Indicator  Lab. 1  Lab. 4 
Marketing  Sales growth  1  4 
Marketing  Growth in market share  2  4 
Marketing  New product introduction (percentage)  2  3 
Marketing  Strengthening of Marketing capability  2  4 
  Marketing indicators’ average  1,75  3,75 
Finance  Earnings growth rate  1  3 
Finance   Return on investment  1  3 
Finance   Stockholders’ capital gains  1  2 
Finance   Asset liquidity  3  3 
  Finance indicators’ average  1,5  2,75 
Quality  Improvement in product quality  3  4 
Operations  Production efficiency and physical 
distribution 
3  4 
R&D  Strengthening of R&D capacity  3  4 
R&D  Improvement in product portfolio  3  3 
  Operations indicators’ average  3  3,75 
HH.RR.  Improvement in employees’ morale  2  3 
HH.RR.  Improvement in employee welfare (e.g. 
salary increase, internal promotion, 







HH.RR.  HH.RR. development.  3  4 
HH.RR.  Reduction in personnel turnover.  3  3 
  HH.RR. indicators’ average.  2,75  3,25 
 
Table A1.  Comparison of Laboratory 1 and Laboratory 4 performances. 
 
Laboratory 4 is consistently better evaluated than Laboratory 1. Indicators are 
classified in Marketing Indicators, Financial Indicators, Operations Indicators (that include 
quality and R&D) and HH.RR. indicators. Laboratory 1 presents its best results in 
Operations, while Laboratory 4, evaluates itself well in Marketing and Operations, although 
their evaluation in other functions is not bad. Distance between laboratories is greatest 
among Marketing and Financial indicators, while the minimum distance belongs to 
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NOTES 
 
i The authors acknowledge the kind encouragement of Dr. Rodolfo Benedix and the valuable assistance of 
Prof. Alejandra Falco, who suggested improvements to an earlier draft of this paper. All remaining errors, 
however, are our sole responsibility. A preliminary version of this work appeared in Pharmaceutical 
Management, Año 2, No. 4, pp. 36-43 (Part 1, September 2000) and Año 3, No. 5, pp. 34-55 (Part 2, January 
2001); the authors thank the editor of Pharmaceutical Management for authorizing the publication of this 
article. 
 
ii See Garvin (1988). 
 
iii We deal with case studies as a research tool rather than as a teaching devise. Research-oriented case studies 
allow generalization “toward theory.” In this regard, they differ from large scale quantitative studies that 
allow inference “towards a population.” See for example Yin, R.K. (1981 y 1984).  
 
iv A basic definition of quality for a pharmaceutical product is the following (Sharp, 1992): “Quality is the 
capacity for the proposed use. A pharmaceutical product is capable for use when:  
 
· It is the correct product 
· It has the adequate power 
· It is free of contamination 
· It has not deteriorated, expired or decomposed 
· It is conditioned in the correct package 
· It has the correct label 
· It is perfectly sealed in its package, to protect it from damage and contamination.” 
 
v See Bingham, R. S. Jr. and Clyde H. Walden (1988). 
  
vi For example, in a household product, such as a transistor radio, major performance components are: power, 
number of frequency bands, size and weight. 
 
vii An approach to the definition of quality dimensions (presented as customer requirements) of a 
pharmaceutical product and an objective way to measure them is presented in: Martín, Fernando and Enrique 
Yacuzzi (1997).  
 
viii In a different context, devises such as a washing machine’s electronic control, which until a few years ago 
could have been considered a secondary feature, is today, thanks to the popularization of these controllers, a 
component of performance. 
 
ix See Garvin (1988), page. 59. 
 
x The country of origin effect is a wide-spread phenomenon, observed in many situations. For example, if no 
other information is available, a French wine will generally be considered to have greater quality than another 
one produced in Eastern Europe, regardless the objective quality of the wines. A similar phenomenon occurs 
in the pharmaceutical market. 
 
xi Although sample size is very small, we have tried to incorporate the opinion of experts with in-depth 
knowledge of the market and industry. At the time of having to choose between a large number of responses 
or quality of the respondent knowledge, we preferred the latter alternative. At any rate, we are aware of the 
small sample size and its limitations. 
 
xii The small sample size does not allow in-depth analysis to determine whether the eight dimensions are in 
fact measuring different concepts. A much greater sample size would be required to determine, through factor   28 
                                                                                                                                                                         
analysis or similar techniques, the relevance of the eight dimension scheme. As far as this study is concerned, 
the eight dimension structure will be considered valid. 
 
xiii It must also be remembered that correlation among variables does not necessarily shows causality; 
correlation must be thoroughly explained and superficial conclusions on causality must be avoided. The 
interested reader can see for example Miles y Huberman (1984) on causality and related issues, such as 
intervening variables. 
 
xiv A method –certainly imperfect but relatively simple— to measure technological content is through a 
mechanization index, defined as: 
 
 Mechanization index  = total machine hours/total man hours. 
 
This index is defined and measured for every production line. In general, as we advance along a productive 
process (i.e., as we get closer to the final customer), the mechanization index decreases: for example, 
mechanization indexes are smaller at the packaging areas than at the manufacturing areas. 
 
xv See, for example, Robbins et al. (1996), Cap. 3. 
 
xvi Availability of information and willingness of laboratory personnel to participate in the study were the 
main reasons for our choice. 
 
xvii Information for these studies was obtained during the year 2000 in several personal interviews with middle 
managers, followed by telephone conversations and e-mail correspondence.  
 
xviii The questionnaire form can be requested to the first author. It is partially based on Kagono et al. (1985). 
 
xix See Shiba (1993). 
 
xx Qualitative case studies always elicit questions about their validity. In this case we have tried to strengthen 
our conviction on data validity by interviewing several people at the same firm and by making redundant 
questions in the questionnaire and during the interviews. 
 
xxi A causal explanation for these high correlation coefficients can be requested to the first author. 
 